SEARCH

SEARCH BY CITATION

References

  • 1
    Hanifin JM. Atopic dermatitis. J Am Acad Dermatol 1982;6:113.
  • 2
    Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999;104:S99108.
  • 3
    Werfel T & Kapp A. Environmental and other major provocation factors in atopic dermatitis. Allergy 1998;53:731739.
  • 4
    Wollenberg A & Bieber T. Atopic dermatitis: from the genes to skin lesions. Allergy 2000;55:205213.DOI: 10.1034/j.1398-9995.2000.00115.x
  • 5
    Ring J & Thewes TM. The clinical expression of allergy in the skin. Allergy 1999;55:192197.
  • 6
    Novak N & Bieber T. The skin as a target for allergic diseases. Allergy 2000;55:103107.DOI: 10.1034/j.1398-9995.2000.00552.x
  • 7
    Wüthrich B. Clinical aspects, epidemiology and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999;83:464470.
  • 8
    Wise F & Sulzberger MB. Footnote on the problem of eczema. Neurodermatitis and lichenification. In: WiseF, SulzbergerMB, editors. The 1933 year book of dermatology and syphilology. Chicago: Year Book, 1933:3839.
  • 9
    Sulzberger M. Historical notes on atopic dermatitis: its names and nature. Semin Dermatol 1983;2:14.
  • 10
    Wüthrich B, Benz A, Skvaril F. IgE and IgG4 levels in children with atopic dermatitis. Dermatologica 1983;166:229235.
  • 11
    Wüthrich B. Neurodermitis atopica sive constitutionalis. A pathogenetic model from the view of an allergologist [Neurodermitis atopica sive constitutionalis. Ein pathogenetisches Modell aus der Sicht des Allergologen]. Akt Dermatol 1983;9:17.
  • 12
    Wüthrich B. Atopic dermatitis flare provoked by inhalant allergens. Dermatologica 1989;178:5153.
  • 13
    Bruijnzeel P, Hamelink M, Prins J, Remmert G, Meyling FG. Immunological aspects of extrinsic and intrinsic asthma. Agents Actions Suppl 1989;28:233238.
  • 14
    Humbert M, Menz G, Ying S, et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999;20:528533.
  • 15
    Werfel T & Kapp A. What do we know about the etiopathology of the intrinsic type of atopic dermatitis? Curr Probl Dermatol 1999;28:2936.
  • 16
    Wüthrich B. What is atopy? Condition, disease or a syndrome? Curr Probl Dermatol 1999;28:18.
  • 17
    Akdis CA, Akdis M, Simon D, et al. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999;113:628634.DOI: 10.1046/j.1523-1747.1999.00720.x
  • 18
    Hanifin J & Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venerol 1980;92:4447.
  • 19
    Kalinke U & Wüthrich B. Clinical and allergologic-immunologic parameters in patients with atopic dermatitis. A prospective study (1989–1997) [Abstract]. Dermatology 1997;195:191.
  • 20
    ETAC Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: first results of ETAC. Pediatr Allergy Immunol 1998;9:116124.
  • 21
    Somos Z & Schneider I. Serum and secretory immunoglobulins in atopic dermatitis. Orv Hetil 1993;134:13591361.
  • 22
    Schäfer T, Dockery D, Kramer U, Behrendt H, Ring J. Experiences with the severity scoring of atopic dermatitis in a population of German pre-school children. Br J Dermatol 1997;137:558562.
  • 23
    Schäfer T, Heinrich J, Wjst M, et al. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. J Allergy Clin Immunol 1999;104:12801284.
  • 24
    Cabon N, Ducombs G, Mortureux P, Perromat M, Taieb A. Contact allergy to aeroallergens in children with atopic dermatitis: comparison with allergic contact dermatitis. Contact Dermatitis 1996;35:2732.
  • 25
    Wüthrich B, Joller-Jemelka H, Helfenstein U, Grob PJ. Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis. Dermatologica 1990;181:9297.
  • 26
    Hochreutener H. Clinical aspects and allergy-immunologic parameters in 40 children 0–7 years of age with atopic dermatitis [Klinische Aspekte und allergologisch-immunologische parameter bei 40 Kindern von 0–7 Jahren mit atopischer Dermatitis]. Monatsschr Kinderheilkd 1991;139:618625.
  • 27
    Walker C, Kägi MK, Ingold P, et al. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 1993;23:145153.
  • 28
    Kägi MK, Wüthrich B, Montano E, et al. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol 1994;103:332340.
  • 29
    Fabrizi G, Romano A, Vultaggio P, et al. Heterogeneity of atopic dermatitis defined by the immune response to inhalant and food allergens. Eur J Dermatol 1999;9:380384.
  • 30
    Waersted A & Hjorth N. Pityrosporum orbiculare– a pathogenic factor in atopic dermatitis of the face, scalp and neck? Acta Derm Venereol Suppl 1985;114:146148.
  • 31
    Jensen-Jarolim E, Poulsen LK, With H, et al. Atopic dermatitis of the face, scalp, and neck: type I reaction to the yeast Pityrosporum ovale? J Allergy Clin Immunol 1992;89:4451.
  • 32
    Tengvall Linder M, Johansson C, Scheynius A, Wahlgren C. Positive atopy patch test reactions to Pityrosporum orbiculare in atopic dermatitis patients. Clin Exp Allergy 2000;30:122131.DOI: 10.1046/j.1365-2222.2000.00702.x
  • 33
    Tengvall Linder M, Johansson C, Zargari A, et al. Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterization of their cytokine profiles. Clin Exp Allergy 1996;26:12861297.
  • 34
    Akdis CA, Akdis M, Trautmann A, Blaser K. Immune regulation in atopic dermatitis. Curr Opin Immunol 2000;12:641648.
  • 35
    Akdis M, Simon HU, Weigl L, et al. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999;163:466475.
  • 36
    Van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992;90:184193.
  • 37
    Abernathy-Carver KJ, Sampson HA, Picker LJ, Leung DY. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 1995;95:913918.
  • 38
    Pene J, Rousset F, Briere F, et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A 1988;85:68806884.
  • 39
    Corry DB & Kheradmand F. Induction and regulation of the IgE response. Nature 1999;402:B1823.
  • 40
    Santamaria Babi LF, Picker LJ, Perez Soler MT, et al. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 1995;181:19351940.
  • 41
    Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870876.
  • 42
    Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999;103:11031111.
  • 43
    Barata LT, Ying S, Meng Q, et al. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Allergy Clin Immunol 1998;101:222230.
  • 44
    Bruijnzeel P, Storz E, Van Der Donk E, Bruijnzeel-Koomen C. Skin eosinophilia in patients with allergic asthma, patients with nonallergic asthma, and healthy controls. II. 20-Hydroxy-leukotriene B4 is a potent in vivo and in vitro eosinophil chemotactic factor in nonallergic asthma. J Allergy Clin Immunol 1993;91:634642.
  • 45
    Simon HU, Yousefi S, Schranz C, et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:39023908.
  • 46
    Wedi B, Raap U, Lewrick H, Kapp A. Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol 1997;100:536543.
  • 47
    Leiferman KM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 1994;94:13101317.
  • 48
    Wedi B, Raap U, Kapp A. Significant delay of apoptosis and Fas resistance in eosinophils of subjects with intrinsic and extrinsic type of atopic dermatitis. Int Arch Allergy Immunol 1999;118:234235.
  • 49
    Leiferman KM, Ackerman SJ, Sampson HA, et al. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 1985;313:282285.
  • 50
    Yawalkar N, Uguccioni M, Schärer J, et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999;113:4348.DOI: 10.1046/j.1523-1747.1999.00619.x
  • 51
    Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651663.
  • 52
    Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860876.
  • 53
    Sampson AP. The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 2000;30 Suppl 1:2227.
  • 54
    Kapp A & Werfel T. Allergic inflammation: skin. Allergy 1999;55:2324.
  • 55
    Horsmanheimo L, Harvima IT, Jarvikallio A, et al. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994;131:348353.
  • 56
    Jarvikallio A, Naukkarinen A, Harvima IT, Aalto ML, Horsmanheimo M. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 1997;136:871877.
  • 57
    Bruijnzeel-Koomen CA, Fokkens WJ, Mudde GC, Bruijnzeel PL. Role of Langerhans cells in atopic disease. Int Arch Allergy Appl Immunol 1989;90:5156.
  • 58
    Pastore S, Fanales-Belasio E, Albanesi C, et al. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 1997;99:30093017.
  • 59
    Bieber T, Dannenberg B, Prinz JC, et al. Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level. J Invest Dermatol 1989;93:215219.
  • 60
    Bieber T. Fc epsilon RI-expressing antigen-presenting cells: new players in the atopic game. Immunol Today 1997;18:311313.
  • 61
    Maurer D, Fiebiger S, Ebner C, et al. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996;157:607616.
  • 62
    Wollenberg A, Wen S, Bieber T. Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod. Cytometry 1999;37:147155.DOI: 10.1002/(sici)1097-0320(19991001)37:2<147::aid-cyto8>3.0.co;2-y
  • 63
    Corne J, Djukanovic R, Thomas L, et al. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics. J Clin Invest 1997;99:879887.
  • 64
    Oppel T, Schuller E, Gunther S, et al. Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis. Br J Dermatol 2000;143:11931198.DOI: 10.1046/j.1365-2133.2000.03887.x
  • 65
    Wollenberg A, Wen S, Bieber T. Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases [Letter]. Lancet 1995;346:16261627.
  • 66
    Yamaguchi M, Lantz CS, Oettgen HC, et al. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997;185:663672.
  • 67
    Coyle AJ, Wagner K, Bertrand C, et al. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med 1996;183:13031310.
  • 68
    Fahy JV, Fleming HE, Wong HH, et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997;155:18281834.
  • 69
    Darsow U, Vieluf D, Ring J. The atopy patch test: an increased rate of reactivity in patients who have an air-exposed pattern of atopic eczema. Br J Dermatol 1996;135:182186.
  • 70
    Sanda T, Yasue T, Oohashi M, Yasue A. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1992;89:653657.
  • 71
    Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of house dust-mite allergen avoidance on atopic dermatitis. Lancet 1996;347:1518.
  • 72
    Scalabrin DM, Bavbek S, Perzanowski MS, et al. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol 1999;104:12731279.
  • 73
    Munir AK, Kjellman NI, Björkstén B. Exposure to indoor allergens in early infancy and sensitization. J Allergy Clin Immunol 1997;100:177181.
  • 74
    Saloga J & Knop J. Does sensitization through the skin occur? Allergy 2000;55:905909.DOI: 10.1034/j.1398-9995.2000.00126.x
  • 75
    Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986;15:487494.
  • 76
    Hanson B, McGue M, Roitman-Johnson B, et al. Atopic disease and immunoglobulin E in twins reared apart and together. Am J Hum Genet 1991;48:873879.
  • 77
    Marsh DG, Neely JD, Breazeale DR, et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:11521156.
  • 78
    Graves PE, Kabesch M, Halonen M, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000;105:506513.
  • 79
    Schäfer T, Kramer U, Vieluf D, et al. The excess of atopic eczema in East Germany is related to the intrinsic type. Br J Dermatol 2000;143:992998.DOI: 10.1046/j.1365-2133.2000.03832.x
  • 80
    Storm van Leeuwen WBZ & Varekamp H. Skin reactivity of human scalp dander in allergic disease [Hautreaktivität auf menschliche Kopfschuppen bei allergischen Erkrankungen]. Klin Wochenschr 1926;5:10231025.
  • 81
    Keller P. The correlation of asthma and eczema [Der Zusammenhang von Asthma und Ekzem]. Arch Derm Syph Berl 1924;148:8291.
  • 82
    Hashem N, Sedlis E, Hirschhorn K, Emmett Holt E. Infantile eczema: evidence of autoimmunity to human skin. Lancet 1963;2:269270.
  • 83
    Natter S, Seiberler S, Hufnagl P, et al. Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients. FASEB J 1998;12:15591569.
  • 84
    Valenta R, Natter S, Seiberler S, et al. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. J Invest Dermatol 1998;111:11781183.DOI: 10.1046/j.1523-1747.1998.00413.x
  • 85
    Ochs S, Muro Y, Si Y, Ge H, Chan EKL, Tan EM. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 2000;105:12111220.
  • 86
    Darsow U, Vieluf D, Ring J. Atopy patch test with different vehicles and allergen concentrations: an approach to standardization. J Allergy Clin Immunol 1995;95:677684.
  • 87
    Wistokat-Wulfing A, Schmidt P, Darsow U, et al. Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis. Clin Exp Allergy 1999;29:513521.DOI: 10.1046/j.1365-2222.1999.00510.x
  • 88
    Ring J, Darsow U, Gfesser M, Vieluf D. The “atopy patch test” in evaluating the role of aeroallergens in atopic eczema. Int Arch Allergy Immunol 1997;113:379383.
  • 89
    Darsow U, Vieluf D, Ring J. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. Atopy Patch Test Study Group. J Am Acad Dermatol 1999;40:187193.
  • 90
    Langeveld-Wildschut EG, Bruijnzeel PL, Mudde GC, et al. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions. J Allergy Clin Immunol 2000;105:10081016.
  • 91
    Godard P, Bousquet J, Michel F. Bronchial asthma: pathophysiology, classic conception and new concepts. Clin Asthma Rev 1997;1:1922.
  • 92
    Bentley AM, Maestrelli P, Saetta M, et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol 1992;89:821829.
  • 93
    Humbert M, Durham SR, Ying S, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against “intrinsic” asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996;154:14971504.
  • 94
    Kleine-Tebbe J & Haustein U. Comparing atopic diseases: relations between bronchial asthma and atopic dermatitis. [Vergleich atopischer Erkrankungen: Beziehung zwischen Asthma bronchiale und atopischer Dermatitis]. Allergo J 2000;9:393402.